Sheeba Irshad - Concepedia

Author

Sheeba Irshad

Also Known As

Elinor Sawyer, Irshad Sheeba, Irshad, S, Irshad, Sheeba, KCL Cancer Biobank, Robert Hills, S Irshad, S. IRSHAD, S. Irshad, Saba Irshad

269

Publications

Citations

H-Index

Concepts

All Affiliations

King's College London Guy's and St Thomas' NHS Foundation Trust University College London Breast Cancer Now King's College Hospital

About

Sheeba Irshad is an author at King's College London specializing in medicine, radiation oncology, and cancer research.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	284
2	Cell Biology	2	2	41
3	Immunology	2	2	174
4	Health Sciences	1	1	26
5	Public Health	1	1	29

Sheeba Irshad

Publications

1.5K

Citations

H-Index

Page 1

	Year	Citations
Safety and immunogenicity of one versus two doses of the COVID-19 vaccine BNT162b2 for patients with cancer: interim analysis of a prospective observational study Leticia Monin, Adam G. Laing, Miguel Muñoz‐Ruiz, The Lancet Oncology	2021	608
RORγt+ Innate Lymphoid Cells Promote Lymph Node Metastasis of Breast Cancers Sheeba Irshad, Fabian Flores‐Borja, Katherine Lawler, Cancer Research	2017	116
Acute Immune Signatures and Their Legacies in Severe Acute Respiratory Syndrome Coronavirus-2 Infected Cancer Patients Sultan Abdul-Jawad, Luca Baù, Thanussuyah Alaguthurai, Cancer Cell Their LegaciesViral PersistenceViral DiagnosticsRespiratory DiseasesImmunology	2021	114
Tumor-Infiltrating B Lymphocyte Profiling Identifies IgG-Biased, Clonally Expanded Prognostic Phenotypes in Triple-Negative Breast Cancer R. J. C. Harris, Anthony Cheung, Joseph Ng, Cancer Research	2021	92
Molecular heterogeneity of triple-negative breast cancer and its clinical implications Sheeba Irshad, Andrew Tutt Current Opinion in Oncology	2011	75
Factors Affecting COVID-19 Outcomes in Cancer Patients: A First Report From Guy's Cancer Center in London Beth Russell, Charlotte Moss, Sophie Papa, Frontiers in Oncology	2020	64
Interim results of the safety and immune-efficacy of 1 versus 2 doses of COVID-19 vaccine BNT162b2 for cancer patients in the context of the UK vaccine priority guidelines Leticia Monin, Adam G. Laing, Miguel Muñoz‐Ruiz, ImmunologyCancer PatientsVaccine HesitancyImmunotherapyCovid-19	2021	60
Risk of COVID-19 death in cancer patients: an analysis from Guy’s Cancer Centre and King’s College Hospital in London Beth Russell, Charlotte Moss, Vallari Shah, British Journal of Cancer	2021	57
COVID-19 Vaccine Safety in Cancer Patients: A Single Centre Experience Alfred Chung Pui So, Harriet McGrath, Jonathan Y. Ting, Cancers	2021	56
Clinico-pathologic features, treatment and outcomes of breast cancer during pregnancy or the post-partum period Ciara C. O’Sullivan, Sheeba Irshad, Zheyu Wang, Breast Cancer Research and Treatment Breast OncologyMedicineClinico-pathologic FeaturesGynecologyMaternal Health	2020	29

Page 1